Psychiatry and Neurology, Neurology · Las Vegas, NV
NPI
1184615098
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
6276 S Rainbow Blvd Ste 100
Las Vegas, NV, 89118
Phone (702) 220-5557
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
3,159 services
Medicare patients, 2024
231
Average age 69
Drug cost, 2024
$5.1M
5,083 prescriptions
Company payments, 2025
$5,066
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mouchir S Harb was code 99213 (office e&m - established), 424 times for 165 patients. In total Mouchir S Harb billed 3,159 services in 17 codes, and Medicare paid $105K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 424 | 165 | $48.87 | $21K |
| 99214 Office E&M - Established | Office | 184 | 106 | $78.78 | $14K |
| 95886 Electrical Nerve Conductivity | Office | 144 | 49 | $68.04 | $9,797 |
| 99205 Office E&M - New | Office | 61 | 61 | $134.00 | $8,174 |
| 95913 Electrical Nerve Conductivity | Office | 38 | 38 | $200.96 | $7,637 |
| 95816 Neurologic | Office | 35 | 35 | $270.61 | $9,471 |
| 95912 Electrical Nerve Conductivity | Office | 34 | 34 | $167.19 | $5,684 |
| 99483 Office/Outpatient Services | Office | 22 | 22 | $188.00 | $4,136 |
By year: 2022 $338K for 9,992 services; 2023 $174K for 5,483 services; 2024 $105K for 3,159 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mouchir S Harb prescribed most often to Medicare patients was Gabapentin, with 337 prescriptions and refills. In total Mouchir S Harb wrote 5,083 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 337 | 469 | 76 | $5,413 |
| Levetiracetam Generic | 326 | 645 | 82 | $9,258 |
| Donepezil Hcl Generic | 296 | 475 | 75 | $2,609 |
| Topiramate Generic | 242 | 411 | 61 | $2,188 |
| Lacosamide Generic | 239 | 309 | 37 | $28K |
| Sodium Chloride 0.9 % Sodium Chloride | 201 | 208 | 23 | $1,480 |
| Pregabalin Generic | 196 | 266 | 47 | $4,158 |
| Primidone Generic | 153 | 294 | 35 | $1,773 |
| Memantine Hcl Generic | 144 | 241 | 35 | $2,210 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 130 | 130 | 12 | $2.0M |
| Carbidopa-Levodopa Carbidopa/Levodopa | 130 | 254 | 26 | $3,015 |
| Duloxetine Hcl Generic | 124 | 196 | 29 | $1,199 |
| Lamotrigine Generic | 107 | 150 | 19 | $1,230 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 105 | 105 | 12 | $1.3M |
| Quetiapine Fumarate Generic | 103 | 147 | 22 | $1,149 |
Brand drugs: 945 claims; generic drugs: 4,121 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mouchir S Harb $5,066 ($5,066 in general payments such as food, travel and fees) from 34 companies. The largest payer was Abbvie Inc. with $901.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 40 | $901 |
| UCB, Inc. UCB.BR | 20 | $461 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 18 | $451 |
| Biogen, Inc. BIIB | 22 | $424 |
| Eisai Inc. 4523.T | 28 | $363 |
| ANI Pharmaceuticals, Inc. ANIP | 10 | $255 |
| Argenx US, Inc. ARGX | 14 | $254 |
| Aucta Pharmaceuticals, Inc. | 13 | $249 |
| Janssen Biotech, Inc. JNJ | 6 | $208 |
| EMD Serono, Inc. MRK.DE | 3 | $174 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.